Cargando…
Competitive ubiquitination activates the tumor suppressor p53
Blocking p53 ubiquitination through disrupting its interaction with MDM2 or inhibiting the MDM2 catalytic activity is the central mechanism by which the tumor suppressor p53 is activated in response to genotoxic challenges. Although MDM2 is first characterized as the major E3 ubiquitin ligase for p5...
Autores principales: | Li, Xingyao, Guo, Mengqi, Cai, Lun, Du, Tingting, Liu, Ying, Ding, Han-Fei, Wang, Hongbo, Zhang, Junran, Chen, Xiaoguang, Yan, Chunhong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7244561/ https://www.ncbi.nlm.nih.gov/pubmed/31796886 http://dx.doi.org/10.1038/s41418-019-0463-x |
Ejemplares similares
-
ATF3 promotes the serine synthesis pathway and tumor growth under dietary serine restriction
por: Li, Xingyao, et al.
Publicado: (2021) -
ATF3 promotes erastin-induced ferroptosis by suppressing system Xc(–)
por: Wang, Liyuan, et al.
Publicado: (2019) -
EC(5)S Ubiquitin Complex Is Recruited by KSHV Latent Antigen LANA for Degradation of the VHL and p53 Tumor Suppressors
por: Cai, Qi-Liang, et al.
Publicado: (2006) -
Tumor suppressor p53 and metabolism
por: Liu, Juan, et al.
Publicado: (2018) -
Structural basis of bacterial effector protein azurin targeting tumor suppressor p53 and inhibiting its ubiquitination
por: Hu, Jianjian, et al.
Publicado: (2023)